Executive Dashboard

Real-time risk stratification and intervention planning

MIMIC-IV Clinical Dataset

ICU patient readmissions (2008-2019)

Modern ICU

Patients

211,354

Readmission Rate

20.5%

Model AUC

63.0%

Top Predictive Features:

1age

36.5%

2procedure count

10.3%

3bilirubin max

8.9%

4potassium min

7.1%

5sodium max

6.2%

Executive Summary

Key insights requiring attention

Analysis Date

Jan 27, 2026

Export Report →

⚠️

Critical Priority

68,962 patients have 80%+ risk scores requiring immediate intervention

Review critical patient list →

💰

Cost Exposure

$938.7M - $2346.7M in preventable readmission costs

Model intervention ROI →

📊

Population Insight

54.2% of patients are high-risk — above the typical 8-10% benchmark

Analyze risk factors →

211,354

Total Analyzed

114,589

High Risk (60%+)

$938.7M - $2346.7M

Cost Exposure Range

63%

Model Accuracy

Total Patients

Analyzed population

High-Risk Members

54.2% of population

Total Cost Exposure

$938.7M - $2346.7M

Based on $10K-$25K benchmarks

Model Performance

ROC-AUC score

High Risk (60-70%)

19,649

Require monitoring

Very High Risk (70-80%)

25,978

Priority outreach

Critical Risk (80%+)

68,962

Immediate intervention

Population Risk Distribution

All 211,354 patients analyzed

Low Risk Medium High Risk

High-Risk Cohort Breakdown

114,589 patients with 60%+ risk score

19,649

High

25,978

Very High

30,779

Critical

38,183

Severe

Top 10 Predictive Features

Features with highest importance scores from Gradient Boosting model

MIMIC-IV dataset has 61 clinical features including vitals, labs, and procedures

Risk by Age Group

Average risk score across all 4 age cohorts

Population Average

52.1%

Highest Risk Group

70+ years

Note: Elderly patients (70+) show elevated risk, indicating need for targeted post-discharge support programs.

Cost Exposure by Risk Tier

Potential savings if readmissions are prevented

60-70%

$188.8M

19,649 patients

70-80%

$284.8M

25,978 patients

80-90%

$386.6M

30,779 patients

90-100%

$433.2M

30,544 patients

Total High-Risk Exposure

$1293.4M

Patients at Risk

106,950

National Benchmarks

Compare against CMS HRRP standards

CMS 2024 Data

Your Readmission Rateneeds improvement

20.5%

National Avg: 15.5%▲ 5.0 pts higher

High-Risk Populationneeds improvement

54.2%

Typical Range: 9.2%▲ 45.0 pts higher

Readmission Rate Quartiles

Top 25%: <12.8%Middle: 12.8-18.2%Bottom 25%: >18.2%

Impact Projection

Model outcomes over time

Reduction Target: 20%

Timeframe: 12 months

Projected Savings

$281.6M

Readmissions Avoided

22,918

Remaining High-Risk

91,671

Goal Tracking

Monitor progress toward targets

○Reduce Critical Risk Patients

Due: Q2 2026

8 / 15 %

53%

○Increase Intervention Enrollment

Due: Q1 2026

312 / 500 patients

62%

○Post-Discharge Contact Rate

Due: Q2 2026

72 / 90 %

80%

0 of 3 goals completeAvg progress: 65%

Intervention ROI Calculator

Model potential savings from evidence-based intervention programs

Select Intervention Type

Typical Cost: $200-$400Effectiveness: 20-30%

Source: TCM Studies

Target Population114,589 patients (100%)

Critical only (10%)All high-risk (100%)

Intervention Effectiveness25% reduction

5% (minimal)Conservative: 15-20%50% (optimistic)

Cost per Intervention$300

$25 (phone call)$600 (intensive)

Readmissions Avoided

28,647

Gross Savings

$429.7M

Program Cost

$34.38M

Net Savings

$395.3M

Return on Investment

1150%

Cost per readmission avoided: $1,200

Assumptions: Based on 114,589 high-risk members with readmission cost of $15,000 (typical range: $10K-$25K). Effectiveness rates based on published literature. Actual results may vary.

Model Information

Demo Data

Data Source

MIMIC-IV Clinical Dataset (2008-2019)

211,354 ICU patient records from Beth Israel Deaconess Medical Center

Model Performance

ROC-AUC

63.0%

Sensitivity

70%

Specificity

58%

NPV

89%

Model Details

AlgorithmGradient Boosting
Features60 clinical variables
Class BalancingSMOTE
Base Rate20.5%

Important: This is a demonstration using MIMIC-IV ICU data (2008-2019). Includes detailed clinical features (vitals, labs, procedures). Cost exposure uses 2024 benchmarks. Not for clinical decision-making.

View methodology details

High-Risk Members

Showing 15 of 124589 members

Critical: 68962Very High: 25978High: 19649

ID↕	Admission↕	Age↕	Meds↕	ICU↕	Risk Score↓	Cost Exposure↕
#12726398	#20000629	60	-	No	100.0%	$10K - $25K
#16725940	#20001461	54	-	No	100.0%	$10K - $25K
#18346781	#20002270	46	-	No	100.0%	$10K - $25K
#12953827	#20003452	65	-	No	100.0%	$10K - $25K
#17249596	#20004227	65	-	No	100.0%	$10K - $25K
#17211434	#20007738	53	-	No	100.0%	$10K - $25K
#15463295	#20008236	46	-	No	100.0%	$10K - $25K
#11389314	#20011281	60	-	No	100.0%	$10K - $25K
#13270054	#20012034	53	-	No	100.0%	$10K - $25K
#18892762	#20012094	48	-	No	100.0%	$10K - $25K
#14997223	#20013887	46	-	No	100.0%	$10K - $25K
#11216730	#20014980	54	-	No	100.0%	$10K - $25K
#18710609	#20015009	46	-	No	100.0%	$10K - $25K
#16899163	#20015872	66	-	No	100.0%	$10K - $25K
#15926029	#20016283	54	-	No	100.0%	$10K - $25K